Does diagnosis/treatment for prostate cancer increase risk for colorectal cancer too?

A newly published study in the journal of Cancer Control has again suggested the possibility that men treated for prostate cancer may be at elevated risk for a secondary diagnosis of colorectal cancer by comparison with similar men never diagnosed with prostate cancer. … READ MORE …

Another new way to diagnose prostate cancer more accurately?

A news item on Friday in the Rochester Democrat and Chronicle describes research ongoing at the Rochetster Institute of Technology into another new way to identify men at high risk for prostate cancer — but using targeted dying agents that will “stick” to the membranes of prostate cancer cells. … READ MORE …

Check what you know about diagnosis of prostate cancer

There’s a new slide presentation on the Medscape web site that is designed to help primary care physicians keep up to date on the initial diagnosis of prostate cancer and its implications. … READ MORE …

Predicting risk for cancer years before the event

There is a lot of media hype about a paper just published in the online journal EBioScience. The paper suggests that it may, perhaps, be able to project risk for diagnosis of cancer (prostate cancer specifically included) as much as 13 years before the actual event. … READ MORE …

Race, obesity, and risk for prostate cancer

By using data from the prospective SELECT trial (the Selenium and Vitamin E Cancer Prevention Trial, conducted between 2001 and 2011), researchers have been able to suggest that obesity is strongly associated with increased risk for prostate cancer diagnosis among African American males compared to non-Hispanic whites. … READ MORE …

Correlating baseline PSA levels to future 10-year risk of prostate cancer diagnosis

A new paper in the Journal of Urology represents an initial attempt, based on a prospective, multi-ethnic cohort of nearly 3,000 men, to determine whether baseline PSA levels can predict, with a high level of reliability, subsequent risk for and consequential diagnosis of prostate cancer. … READ MORE …

A completely new test for risk of prostate cancer? But is it good enough?

New data published in the journal Applied Materials and Interfaces (along with media information that should be read with some caution) suggests the possibility of a new way to test for risk of prostate cancer based on the adhesion of citrate-capped gold nanoparticles to biomolecules in truly tiny blood samples. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,324 other followers